Litigation Details for Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. (D. Del. 2020)

Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. (D. Del. 2020)

Docket		Date Filed	2020-01-28
Court	District Court, D. Delaware	Date Terminated
Cause	35:1 Patent Infringement	Assigned To	Jennifer L. Hall
Jury Demand	Defendant	Referred To
Parties	GLENMARK PHARMACEUTICALS LIMITED
Patents	10,543,179; 9,187,405
Attorneys	Sarah E. Spires
Firms	Stamoulis & Weinblatt LLC
Link to Docket	External link to docket

Details for Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-01-28				External link to document
2020-01-28	1	Complaint	mg, prior to expiration of U.S. Patent No. 10,543,179 (“the ’179 patent”). ME1 32500579v.1 Case 1…. This is an action for patent infringement arising under the patent laws of the United States, …prior to the expiration of U.S. Patent No. 9,187,405 (“the ’405 patent”). 9. In …)(IV), with respect to the ’405 patent asserting that the ’405 patent is invalid, unenforceable, and/…20 Page 7 of 40 PageID #: 7 patent asserting that the ’405 patent is invalid, unenforceable, and/or	External link to document
2020-01-28	125	Notice of Service	' Invalidity Contentions Regarding U.S. Patent No. 10,543,179 filed by Novartis Pharmaceuticals Corporation… 28 January 2020 1:20-cv-00133 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2020-01-28	132	Notice of Service	HECs Invalidity Contentions Regarding U.S. Patent No. 10,543,179 filed by HEC Pharm Co., Ltd., HEC Pharm … 28 January 2020 1:20-cv-00133 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2020-01-28	149	Notice of Service	Final Invalidity Contentions Regarding U.S. Patent No. 10,543,179 filed by Novartis Pharmaceuticals Corporation… 28 January 2020 1:20-cv-00133 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document